Bi et al. demonstrate that fluoxetine inhibition of SMPD1 in GBM was found to induce tumor cell death by reducing EGFR signaling and increasing lysosomal stress, resulting in complete tumor regression in mice [87]. This evidence concerns the gene EGFR and glioblastoma.